Cargando…
Targeting MDK Abrogates IFN-γ-Elicited Metastasis inCancers of Various Origins
IFN-γ is a pleiotropic cytokine with immunomodulatory and tumoricidal functions. It has been used as an anti-tumor agent in adjuvant therapies for various cancers. Paradoxically, recent advances have also demonstrated pro-tumorigenic effects of IFN-γ, especially in promoting cancer metastasis, with...
Autores principales: | Zheng, Luyu, Liu, Qun, Li, Ruijun, Chen, Shibin, Tan, Jingyu, Li, Lina, Dong, Xichen, Huang, Changzhi, Wen, Tao, Liu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210922/ https://www.ncbi.nlm.nih.gov/pubmed/35747815 http://dx.doi.org/10.3389/fonc.2022.885656 |
Ejemplares similares
-
Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line
por: Liu, Qun, et al.
Publicado: (2022) -
Application MDK-parameters
por: Dupuy, B
Publicado: (1998) -
Missing items MDK 25
por: Kamber, I
Publicado: (1985) -
Proceedings of the Fifth Modulator-KIystron Workshop MDK2001
por: Kehrer, T
Publicado: (2001) -
Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade
por: Vackova, Julie, et al.
Publicado: (2020)